Deutsche Bank Downgrades Quest Diagnostics To Hold

Analysts at Deutsche Bank downgraded

from Buy to Hold. The price target for Quest Diagnostics has been raised from $77.00 to $80.00. Quest Diagnostics shares have gained 33.18% over the past 52 weeks, while the S&P 500 index has surged 12.90% in the same period. Quest Diagnostics' shares closed at $77.23 in pre-market trading.